Authors: Buchanan, MR Maclean, GA Brister, SJ

Citation: Mr. Buchanan et al., Selective and sustained inhibition of surface-bound thrombin activity by intimatan/heparin cofactor II and its relevance to assessing systemic anticoagulation in vivo, ex vivo and in vitro, THROMB HAEM, 86(3), 2001, pp. 909-913

Authors: Buchanan, MR Schwartz, L Bourassa, MG Brister, SJ Peniston, CM

Citation: Mr. Buchanan et al., Results of the BRAT study - A pilot study investigating the possible significance of ASA nonresponsiveness on the benefits and risks of ASA on thrombosis in patients undergoing coronary artery bypass surgery, CAN J CARD, 16(11), 2000, pp. 1385-1390

Authors: Buchanan, MR Brister, SJ

Citation: Mr. Buchanan et Sj. Brister, Anticoagulant and antithrombin effects of intimatan, a heparin cofactor IIagonist, THROMB RES, 99(6), 2000, pp. 603-612

Authors: Buchanan, MR Brister, SJ

Citation: Mr. Buchanan et Sj. Brister, A rationale for targeting antithrombotic therapy at the vessel wall: Improved antithrombotic effect and decreased risk of bleeding, WIEN KLIN W, 111(3), 1999, pp. 81-89